0001654954-20-000310.txt : 20200110
0001654954-20-000310.hdr.sgml : 20200110
20200110213645
ACCESSION NUMBER: 0001654954-20-000310
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200108
FILED AS OF DATE: 20200110
DATE AS OF CHANGE: 20200110
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: NIFFENEGGER KATHI
CENTRAL INDEX KEY: 0001620146
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37619
FILM NUMBER: 20522409
MAIL ADDRESS:
STREET 1: C/O STELLAR BIOTECHNOLOGIES, INC.
STREET 2: 332 EAST SCOTT STREET
CITY: PORT HUENEME
STATE: CA
ZIP: 93041
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Edesa Biotech, Inc.
CENTRAL INDEX KEY: 0001540159
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: A1
FISCAL YEAR END: 0930
BUSINESS ADDRESS:
STREET 1: 100 SPY COURT
CITY: MARKHAM
STATE: A6
ZIP: L3R 5H6
BUSINESS PHONE: (905) 475-1234
MAIL ADDRESS:
STREET 1: 100 SPY COURT
CITY: MARKHAM
STATE: A6
ZIP: L3R 5H6
FORMER COMPANY:
FORMER CONFORMED NAME: Stellar Biotechnologies, Inc.
DATE OF NAME CHANGE: 20120120
4
1
section16.xml
FORM 4
X0306
4
2020-01-08
0001540159
Edesa Biotech, Inc.
EDSA
0001620146
NIFFENEGGER KATHI
C/O EDESA BIOTECH, INC.
100 SPY COURT
MARKHAM
A6
L3R 5H6
ONTARIO, CANADA
true
Chief Financial Officer
Common Shares
2020-01-08
4
A
false
1218
4.11
A
1218
I
By Trust
Common Share Warrants (Right to Buy)
4.80
2020-01-08
4
A
false
914
A
2020-07-08
2023-07-08
Common Shares
914
914
I
By Trust
Common Share Warrants (Right to Buy)
4.00
2020-01-08
4
A
false
609
A
2020-07-08
2020-11-08
Common Shares
609
609
I
By Trust
The reported securities are included within 1,218 Common Shares purchased by the reporting person for $4.11 per Common Share. Each Common Share includes the purchase of Class A Warrants to purchase 0.75 of a Common Share, and Class B Warrants to purchase 0.50 of a Common Share.
Consists of Class A Warrants to purchase Common Shares. The Class A Warrants are exercisable beginning on July 8, 2020 and expire on July 8, 2023.
Consists of Class B Warrants to purchase Common Shares. The Class B Warrants are exercisable beginning on July 8, 2020 and expire on November 8, 2020.
/s/ Kathi Niffenegger
2020-01-10